OIG - Office of Inspector General
01/06/2025 | Press release | Distributed by Public on 01/06/2025 17:42
Athira Pharma Inc. Agrees to Pay $4M to Settle False Claims Act Allegations Related to Scientific Research Misconduct
Athira Pharma Inc. Agrees to Pay $4M to Settle False Claims Act Allegations Related to Scientific Research Misconduct
Athira Pharma Inc., located in Bothwell, Washington, has agreed to pay $4,068,698 to resolve allegations that it violated the False Claims Act (FCA) by failing to report allegations of research misconduct to the National Institutes of Health (NIH) and Department of Health and Human Services (HHS) Office of Research Integrity in grant applications and grant award progress reports and assurances.
Action Details
- Date:January 6, 2025
- Agency:U.S. Department of Justice
-
Enforcement Types:
- Criminal and Civil Actions
Share
OIG - Office of Inspector General published this content on January 06, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 06, 2025 at 23:42 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io